Maurizio Nava. SPONSOR. ALL SPONSOR. The impact of neoadjuvant treatments on breast and axillary Surgery. Management of low-risk DCIS. Randomized controlled trials in breast surgery. Standardised outcome assessment in breast surgery. The impact of .
Dr Maurizio NAVA is an oncologic surgeon, specialized in Plastic and Reconstructive surgery, head of the Plastic Surgery Unit at the “Instituto Nazionale dei Tumori” in Milan. He is also the President of the Oncologic Reconstructive Surgery School, and member of the Italian Society of Plastic Surgery, the European Society of Surgical Oncology, American Society of Plastic [ ].
Guillermina Nava is a practicing Plastic Surgery doctor in Detroit, MI. Overview. Dr. Nava graduated from the University Of Rochester School Of Medicine And Dentistry in 2001.3.9/5(7).
Conflicting evidence challenges clinical decision‐making when breast reconstruction is considered in the context of radiotherapy. Current literature was evaluated and key statements on topical issues were generated and discussed by an expert panel at the International Oncoplastic Breast Surgery Meeting in Author: M. B. Nava, J. R. Benson, W. Audretsch, P. Blondeel, G. Catanuto, M. W. Clemens, P. G. Cordeiro, P.
Chair: Maurizio Nava. Breast surgery has undergone vast changes since the 1970s, when the only choice was mastectomy. These days, surgeons, in agreement with patients, must make challenging decisions about the most appropriate surgery according to a much wider range of options.